Citation Impact
Citing Papers
Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies
2008 Standout
Randomised trial of addition of lamivudine or lamivudine plus loviride to zidovudine-containing regimens for patients with HIV-1 infection: the CAESAR trial
1997
CD4+ Count–Guided Interruption of Antiretroviral Treatment
2006 Standout
The PHQ-8 as a measure of current depression in the general population
2008 Standout
Ferroptosis: molecular mechanisms and health implications
2020 Standout
No health without mental health
2007 Standout
A proteomic atlas of senescence-associated secretomes for aging biomarker development
2020 Standout
Concurrent infections and HIV pathogenesis
2000
Personalized Telehealth in the Future: A Global Research Agenda
2016
Allelic variants of the thiopurine s-methyltranferase deficiency in patients with ulcerative colitis and in healthy controls
2000
Rheumatoid arthritis
2016 Standout
The CD85j+ NK Cell Subset Potently Controls HIV-1 Replication in Autologous Dendritic Cells
2008 StandoutNobel
Dendritic injury is a pathological substrate for human immunodeficiency virus—related cognitive disorders
1997
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
2019 Standout
A meta-analysis of the efficacy and toxicity of combining disease-modifying anti-rheumatic drugs in rheumatoid arthritis based on patient withdrawal
2005
Changing patterns of mortality across Europe in patients infected with HIV-1
1998
The Patient Health Questionnaire Somatic, Anxiety, and Depressive Symptom Scales: a systematic review
2010 Standout
The Spectrum of Engagement in HIV Care and its Relevance to Test-and-Treat Strategies for Prevention of HIV Infection
2011 Standout
EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)
2006
Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy
2013 Standout
The molecular machinery of regulated cell death
2019 Standout
Homozygous Defect in HIV-1 Coreceptor Accounts for Resistance of Some Multiply-Exposed Individuals to HIV-1 Infection
1996 Standout
Common Superficial Fungal Infections in Patients with AIDS
1996
A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or Less
1997 Standout
AIDS DEMENTIA COMPLEX
1999
Functions of natural killer cells
2008 Standout
Reconstitution of NK Cell Activity in HIV-1 Infected Individuals Receiving Antiretroviral Therapy
2000
HIV-Specific Antibodies But Not T-Cell Responses Are Associated With Protection in Seronegative Partners of HIV-1-Infected Individuals in Cambodia
2006 StandoutNobel
Risk of all-cause mortality associated with nonfatal AIDS and serious non-AIDS events among adults infected with HIV
2010
Delayed Progression to Death and to AIDS in a Hong Kong Cohort of Patients with Advanced HIV Type 1 Disease During the Era of Highly Active Antiretroviral Therapy
2004
Induction of neutralising antibodies restricts the use of human granulocyte/macrophage colony stimulating factor for vaccine studies in rhesus macaques
2004 StandoutNobel
CD4 cell and CD8 cell-mediated resistance to HIV-1 infection in exposed uninfected intravascular drug users in Vietnam
2003 StandoutNobel
The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials
1997 Standout
Dendritic Anomalies in Disorders Associated with Mental Retardation
2000 Standout
Prophylaxis against Opportunistic Infections in Patients with Human Immunodeficiency Virus Infection
2000
Inflammatory Bowel Disease
2002 Standout
Human immunodeficiency virus (HIV) nef-specific cytotoxic T lymphocytes in noninfected heterosexual contact of HIV-infected patients.
1994
HMGB1 in health and disease
2014
The Selective Downregulation of Class I Major Histocompatibility Complex Proteins by HIV-1 Protects HIV-Infected Cells from NK Cells
1999 Nobel
A new synthetic TLR4 agonist, GLA, allows dendritic cells targeted with antigen to elicit Th1 T‐cell immunity in vivo
2011 StandoutNobel
Cerebrospinal-fluid HIV-1 RNA and drug concentrations after treatment with lamivudine plus zidovudine or stavudine
1998
Rheumatoid arthritis
2010 Standout
Hepatitis C Virus‐Specific Cytolytic T Lymphocyte and T Helper Cell Responses in Seronegative Persons
1997 StandoutNobel
Telehealth
2017 Standout
Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma
2005 Standout
Effects of chloroquine on viral infections: an old drug against today's diseases
2003 Standout
Assessing the Viorologic and Adherence Benefits of Patient-Selected HIV Treatment Partners in a Resource-limited Setting
2010
Practice Guidelines for the Management of Cryptococcal Disease
2000 Standout
The immunopathology of sepsis and potential therapeutic targets
2017 Standout
Review of deep learning: concepts, CNN architectures, challenges, applications, future directions
2021 Standout
Increased IFN-γ production by NK and CD3+/CD56+ cells in sexually HIV-1-exposed but uninfected individuals
2006
Risk of Cardiovascular Disease from Antiretroviral Therapy for HIV: A Systematic Review
2013
Circulating microRNAs in Sera Correlate with Soluble Biomarkers of Immune Activation but Do Not Predict Mortality in ART Treated Individuals with HIV-1 Infection: A Case Control Study
2015 Standout
Randomized Study of Sulfamethoxazole-trimethoprim versus Aerosolized Pentamidine for Secondary Prophylaxis of Pneumocystis carinii Pneumonia in Patients with AIDS
1995
Beyond Adoption: A New Framework for Theorizing and Evaluating Nonadoption, Abandonment, and Challenges to the Scale-Up, Spread, and Sustainability of Health and Care Technologies
2017 Standout
Inflammatory bone loss: pathogenesis and therapeutic intervention
2012 Standout
Immunotherapy for the Adjunctive Treatment of Sepsis: From Immunosuppression to Immunostimulation. Time for a Paradigm Change?
2013
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
2015 Standout
Effects of glucocorticoids on radiological progression in rheumatoid arthritis
2007
Deep Learning in Selected Cancers’ Image Analysis—A Survey
2020
Declining Prevalence of HIV-Infected Individuals at Risk of Transmitting Drug-Resistant HIV in Denmark during 1997–2004
2006
Human immunodeficiency virus 1 downregulates cell surface expression of the non-classical major histocompatibility class I molecule HLA-G1
2004 StandoutNobel
CD56 identifies monocytes and not natural killer cells in rhesus macaques
1999
Combination Antiretroviral Therapy and the Risk of Myocardial Infarction
2003 Standout
Psychiatric and neurocognitive disorders among HIV-positive and negative veterans in care
2004
Melaleuca alternifolia(Tea Tree) Oil: a Review of Antimicrobial and Other Medicinal Properties
2006 Standout
Rifampin Combination Therapy for Nonmycobacterial Infections
2010
Immune Function and Phenotype Before and After Highly Active Antiretroviral Therapy
1999
Sexually Transmitted Diseases Treatment Guidelines, 2010
2011 Standout
Current and Emerging Azole Antifungal Agents
1999 Standout
Activating Receptors and Coreceptors Involved in Human Natural Killer Cell-Mediated Cytolysis
2001 Standout
Onychomycosis
1993
Immune Function and Phenotype Before and After Highly Active Antiretroviral Therapy
2006
Human Dendritic Cells Activate Resting Natural Killer (NK) Cells and Are Recognized via the NKp30 Receptor by Activated NK Cells
2002 StandoutNobel
Inflammatory Blockade Restores Adult Hippocampal Neurogenesis
2003 StandoutScience
Screening for HIV: U.S. Preventive Services Task Force Recommendation Statement
2013
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Low dose glucocorticoids in early rheumatoid arthritis.
2004
Interventions for enhancing medication adherence
2014 Standout
HIV protease inhibitors induce senescence and alter osteoblastic potential of human bone marrow mesenchymal stem cells: beneficial effect of pravastatin
2013
Characterization of CD56–/CD16+natural killer (NK) cells: A highly dysfunctional NK subset expanded in HIV-infected viremic individuals
2005
HLAand HIV-1: Heterozygote Advantage andB*35-Cw*04Disadvantage
1999 Science
Penetration of Drugs through the Blood-Cerebrospinal Fluid/Blood-Brain Barrier for Treatment of Central Nervous System Infections
2010 Standout
Is AIDS a floating point between HIV seroconversion and death? Insights from the Tricontinental Seroconverter Study.
1998
A Review of Telehealth Service Implementation Frameworks
2014
Relative risk of cardiovascular disease among people living with HIV : a systematic review and meta‐analysis
2012
Viral Subversion of the Immune System
2000
Predictors of Mortality in Staphylococcus aureus Bacteremia
2012
Prosthetic Joint Infection
2014 Standout
Distinctive NK-cell receptor repertoires sustain high-level constitutive NK-cell activation in HIV-exposed uninfected individuals
2007 StandoutNobel
Cervarix™: a vaccine for the prevention of HPV 16, 18-associated cervical cancer
2008
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Mild Cognitive Impairment and Risk of Mortality in HIV-1 Infection
1998
Antimicrobial Resistance in ESKAPE Pathogens
2020 Standout
Works of C Pedersen being referenced
Immunization of early adolescent females with human papillomavirus type 16 and 18 L1 virus-like particle vaccine containing AS04 adjuvant.
2007
Double blind placebo controlled trial of pulse treatment with methylprednisolone combined with disease modifying drugs in rheumatoid arthritis.
1990
Abacavir and risk of myocardial infarction in HIV‐infected patients on highly active antiretroviral therapy: a population‐based nationwide cohort study
2009
Early telemedicine training and counselling after hospitalization in patients with severe chronic obstructive pulmonary disease: a feasibility study
2015
Epidemiology of AIDS Dementia Complex in Europe
1996
Major but differential decline in the incidence of Staphylococcus aureus bacteraemia in HIV‐infected individuals from 1995 to 2007: a nationwide cohort study*
2011
Pharmacokinetic Interaction between Rifampin and the Combination of Indinavir and Low‐Dose Ritonavir in HIV‐Infected Patients
2004
Survival differences in European patients with AIDS, 1979–89
1994
A MODEL FOR ASSESSMENT OF TELEMEDICINE APPLICATIONS: MAST
2012
Clinical Progression of HIV Infection: Role of NK Cells
1997
Factors Associated with the Development of Pneumocystis carinii Pneumonia in 5,025 European Patients with AIDS
1995
Resistance profiles and adherence at primary virological failure in three different highly active antiretroviral therapy regimens: analysis of failure rates in a randomized study
2004
White nails in AIDS/ARC due to Trichophyton rubrum infection
1988
Prevalence of HIV infection in seronegative high-risk individuals examined by virus isolation and PCR.
1991
Prevention of Pneumocystis carinii pneumonia relapse in AIDS patients. The efficacy and tolerability of low-dose sulfamethoxazole-trimethoprim.
1993
Bone mineral density changes in protease inhibitor-sparing vs. nucleoside reverse transcriptase inhibitor-sparing highly active antiretroviral therapy: data from a randomized trial*
2010
Application of deep learning for autonomous detection and localization of colorectal polyps in wireless colon capsule endoscopy
2019
New immunological serum markers in bacteraemia: anti-inflammatory soluble CD163, but not proinflammatory high mobility group-box 1 protein, is related to prognosis
2008